MENU
Forex Education Symbols

(AKR.L)
30 4 (15.38%) 02-21 16:30
Open: 22 Prev Close: 26
High: 31 Low: 22
Volume: 13,416 Market Cap: 3M
Year High: 189.98 Year Low: 10.5
Stock Technical Analysis
Overall       
Targets Six months: 41.50    One year: 59.57
Supports Support1: 10.50   Support2: 8.74
Resistances Resistance1: 35.53    Resistance2: 51.00 
Pivot Point 31.03 
Moving Averages MA(5): 29.00      MA(20): 28.95 

MA(100): 47.60      MA(250): 80.994 
MACD MACD(12,26): 0.95      Signal(12,26,9): 1.20 
Stochastic Oscillator %K(14,3): 39.18      %D(3): 44.98 
RSI RSI(14): 53.72 
52-Week High: 189.98  Low: 10.50  Change(%): -71.4
Average Volume(K) 3-Month: 852  10-Days: 711.539978
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
AKR.L has closed above bottom band by 41.5%. Bollinger Bands are 34.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Digging Up the Facts on Akers Biosciences, Inc. (AKER)
Wed, 21 Feb 2018 18:33:45 GMT

A Preview of Valuations Summary: Aethlon Medical, Inc. (AEMD), Akers ...
Wed, 21 Feb 2018 14:48:45 GMT

Akers Biosciences funded to profitability as it gears up for transformational year
Wed, 31 Jan 2018 12:45:00 GMT

Analysts Give These Stocks Mix Nod: Facebook, Inc. (FB), Akers Biosciences ...
Tue, 20 Feb 2018 15:56:15 GMT

Hesitation to buy these stock might leave you disappointed: Akers Biosciences ...
Thu, 15 Feb 2018 13:41:15 GMT

Taking a Fresh Look at Akers Biosciences, Inc. (AKER)
Mon, 05 Feb 2018 20:48:45 GMT

Stoxline Canada

Stock Chart London

Option Calculator

Financials
EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M)
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Valuation
P/E
P/E Growth Ratio
P/BV
P/S 11.64
P/CF